☰

Larryn W. Peterson, Ph.D. - Publications

Affiliations: 
2009 Chemistry University of Southern California, Los Angeles, CA, United States 
Area:
organophosphorus, bioorganic and medicinal chemistry
Tree Info Similar researchers PubMed Report error

22 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Magee CA, Peterson LW, Cafiero M. The effects of ligand charge, orientation and size on the binding of potential inhibitors for aldehyde dehydrogenase Computational and Theoretical Chemistry. 1185: 112868. DOI: 10.1016/J.Comptc.2020.112868  0.319
2019 Roldan RJ, Pajarillo AO, Greenberg JD, Karlinsey JE, Cafiero M, Frawley ER, Peterson LW. Propargylglycine-based antimicrobial compounds are targets of TolC-dependent efflux systems in Escherichia coli. Bioorganic & Medicinal Chemistry Letters. 126875. PMID 31836438 DOI: 10.1016/J.Bmcl.2019.126875  0.323
2019 Perchik MC, Peterson LW, Cafiero M. The effects of ligand deprotonation on the binding selectivity of the phenylalanine hydroxylase active site Computational and Theoretical Chemistry. 1153: 19-24. DOI: 10.1016/J.Comptc.2019.02.015  0.317
2018 Evans R, Peterson L, Cafiero M. Evaluation of hybrid and pure DFT methods for the binding of novel ligands in the tyrosine hydroxylase enzyme Computational and Theoretical Chemistry. 1140: 145-151. DOI: 10.1016/J.Comptc.2018.08.009  0.312
2017 Malkowski SN, Dishuck CF, Lamanilao GG, Embry CP, Grubb CS, Cafiero M, Peterson LW. Design, Modeling and Synthesis of 1,2,3-Triazole-Linked Nucleoside-Amino Acid Conjugates as Potential Antibacterial Agents. Molecules (Basel, Switzerland). 22. PMID 28994722 DOI: 10.3390/Molecules22101682  0.372
2016 Rote JC, Malkowski SN, Cochrane CS, Bailey GE, Brown NS, Cafiero M, Peterson LW. Catechol reactivity: Synthesis of dopamine derivatives substituted at the 6-position Synthetic Communications. 47: 435-441. DOI: 10.1080/00397911.2016.1269350  0.314
2012 Hernández AR, Peterson LW, Kool ET. Steric restrictions of RISC in RNA interference identified with size-expanded RNA nucleobases. Acs Chemical Biology. 7: 1454-61. PMID 22646660 DOI: 10.1021/Cb300174C  0.473
2011 Krueger AT, Peterson LW, Chelliserry J, Kleinbaum DJ, Kool ET. Encoding phenotype in bacteria with an alternative genetic set. Journal of the American Chemical Society. 133: 18447-51. PMID 21981660 DOI: 10.1021/Ja208025E  0.473
2011 Zakharova VM, Serpi M, Krylov IS, Peterson LW, Breitenbach JM, Borysko KZ, Drach JC, Collins M, Hilfinger JM, Kashemirov BA, McKenna CE. Tyrosine-based 1-(S)-[3-hydroxy-2-(phosphonomethoxy)propyl]cytosine and -adenine ((S)-HPMPC and (S)-HPMPA) prodrugs: synthesis, stability, antiviral activity, and in vivo transport studies. Journal of Medicinal Chemistry. 54: 5680-93. PMID 21812420 DOI: 10.1021/Jm2001426  0.731
2011 Peterson LW, Kim JS, Kijek P, Mitchell S, Hilfinger J, Breitenbach J, Borysko K, Drach JC, Kashemirov BA, McKenna CE. Synthesis, transport and antiviral activity of Ala-Ser and Val-Ser prodrugs of cidofovir. Bioorganic & Medicinal Chemistry Letters. 21: 4045-9. PMID 21641218 DOI: 10.1016/J.Bmcl.2011.04.126  0.594
2011 Williams M, Krylov IS, Zakharova VM, Serpi M, Peterson LW, Krečmerová M, Kashemirov BA, McKenna CE. Cyclic and acyclic phosphonate tyrosine ester prodrugs of acyclic nucleoside phosphonates Collection of Czechoslovak Chemical Communications. 12: 167-170. DOI: 10.1135/Css201112167  0.723
2010 Peterson LW, Sala-Rabanal M, Krylov IS, Serpi M, Kashemirov BA, McKenna CE. Serine side chain-linked peptidomimetic conjugates of cyclic HPMPC and HPMPA: synthesis and interaction with hPEPT1. Molecular Pharmaceutics. 7: 2349-61. PMID 20929265 DOI: 10.1021/Mp100186B  0.741
2010 McKenna CE, Kashemirov BA, Peterson LW, Goodman MF. Modifications to the dNTP triphosphate moiety: from mechanistic probes for DNA polymerases to antiviral and anti-cancer drug design. Biochimica Et Biophysica Acta. 1804: 1223-30. PMID 20079885 DOI: 10.1016/J.Bbapap.2010.01.005  0.536
2010 Tehler U, Nelson CH, Peterson LW, Provoda CJ, Hilfinger JM, Lee KD, McKenna CE, Amidon GL. Puromycin-sensitive aminopeptidase: an antiviral prodrug activating enzyme. Antiviral Research. 85: 482-9. PMID 19969024 DOI: 10.1016/J.Antiviral.2009.12.003  0.566
2009 Peterson LW, McKenna CE. Prodrug approaches to improving the oral absorption of antiviral nucleotide analogues. Expert Opinion On Drug Delivery. 6: 405-20. PMID 19382883 DOI: 10.1517/17425240902824808  0.582
2009 McKenna CE, Peterson LW, Kashemirov BA, Serpi M, Mitchell S, Kim JS, Hilfinger JM, Drach JC. New peptidomimetic prodrugs of acyclic and cyclic cidofovir: sar studies of chemical and enzymatic activation mechanisms Antiviral Research. 82: A75. DOI: 10.1016/J.Antiviral.2009.02.206  0.553
2009 Krylov IS, Peterson LW, Kashemirov BA, Breitenbach J, Borysco K, Drach JC, Kim JS, Hilfinger JM, McKenna CE. In vitro transport, activation and antiviral evaluation of new HPMPA prodrugs synthesized on a solid support Antiviral Research. 82: A75. DOI: 10.1016/J.Antiviral.2009.02.205  0.739
2009 Sala-Rabanal M, Peterson LW, Serpi M, Krylov IS, Kashemirov BA, Kim JS, Mitchell S, Hilfinger JM, McKenna CE. Interactions Between the Human Oligopeptide Transporter, hPepT1 and Serine Side-chain-linked Cidofovir Prodrugs Antiviral Research. 82: A53-A54. DOI: 10.1016/J.Antiviral.2009.02.124  0.725
2008 Eriksson U, Peterson LW, Kashemirov BA, Hilfinger JM, Drach JC, Borysko KZ, Breitenbach JM, Kim JS, Mitchell S, Kijek P, McKenna CE. Serine peptide phosphoester prodrugs of cyclic cidofovir: synthesis, transport, and antiviral activity. Molecular Pharmaceutics. 5: 598-609. PMID 18481868 DOI: 10.1021/Mp8000099  0.683
2008 Peterson LW, Kashemirov BA, Eriksson U, Kim J, Mitchell S, Kijek P, Lee K, Hilfinger JM, McKenna CE. Serine Side-Chain-linked Peptidomimetic Prodrugs of Cidofovir and Cyclic Cidofovir: C-Ester Effects on Transport and Activation Antiviral Research. 78: A46. DOI: 10.1016/J.Antiviral.2008.01.091  0.679
2007 PETERSON L, KASHEMIROV B, SAEJUENG K, BREITENBACH J, BORYSKO K, DRACH J, KIM J, KIJEK P, MITCHELL S, HILFINGER J. Novel Synthetic Approaches to Cidofovir and Foscarnet Prodrugs Antiviral Research. 74: A74-A74. DOI: 10.1016/J.Antiviral.2007.01.122  0.672
2007 PETERSON L, KASHEMIROV B, BLAZEWSKA K, BREITENBACK J, BORYSKO K, DRACH J, KIM J, KIJEK P, HILFINGER J, MCKENNA C. Synthesis and Structure–Activity Aspects of Some Cyclic Cidofovir Peptidomimetic Prodrugs Antiviral Research. 74: A33-A33. DOI: 10.1016/J.Antiviral.2007.01.023  0.539
Show low-probability matches.